Clinical Trial

A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Research purpose： To evaluate the efficacy and safety of R-mini-MCOP in first-line treatment of primary treatment of diffuse large B-cell lymphoma (DLBCL) in elderly patients Experimental design： Single-arm, multicenter, prospective study
Trial Details
NCT Number NCT06921044
Lead Sponsor Xiaohui He
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.
Conditions Diffuse Large B-Cell Lymphoma
Enrollment 33 participants
Start Date 2025-04-16
Primary Completion 2026-02-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-10